Jenni M. Vuola

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans

Samuel McConkey, William H. H. Reece, Vasee Moorthy et al. · Nature Medicine · 2003 · 558 citations

Life Sciences, Biotechnology, Immunology +16

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

Daniel P. Webster, Susanna Dunachie, Jenni M. Vuola et al. · Proceedings of the National Academy of Sciences · 2005 · 244 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

High Rates of Clinical and Subclinical Tuberculosis among HIV-Infected Ambulatory Subjects in Tanzania

Lillian Mtei, Mecky Matee, Oliver Herfort et al. · Clinical Infectious Diseases · 2005 · 189 citations · Full text

Public Health, Immunology, Infectious Diseases +17

Differential Immunogenicity of Various Heterologous Prime-Boost Vaccine Regimens Using DNA and Viral Vectors in Healthy Volunteers

Jenni M. Vuola, Sheila M. Keating, Daniel P. Webster et al. · The Journal of Immunology · 2005 · 154 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Durable Human Memory T Cells Quantifiable by Cultured Enzyme-Linked Immunospot Assays Are Induced by Heterologous Prime Boost Immunization and Correlate with Protection against Malaria

Sheila M. Keating, Philip Bejon, Tamara Berthoud et al. · The Journal of Immunology · 2005 · 126 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17